| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | -2,6 k € | -87.7% | -1,4 k € | +67.7% | -4,4 k € | -243.7% | -1,3 k € | -33.1% | -951,5 € | -1.4% | -938,2 € | -39.8% | -671,0 € | +38.1% | -1,1 k € | -298.9% | 545,2 € | -96.8% | 16,8 k € | +317.1% | -7,7 k € | -79.3% | -4,3 k € | -280.0% | 2,4 k € | -74.9% | 9,6 k € | +144.6% | 3,9 k € | -0.5% | 3,9 k € | +41.7% | 2,8 k € | -48.9% | 5,4 k € | -76.8% | 23,4 k € | +88.3% | 12,4 k € | |
| EBITDA | -2,6 k € | -46.2% | -1,8 k € | +61.8% | -4,7 k € | -180.3% | -1,7 k € | -30.1% | -1,3 k € | -1.0% | -1,3 k € | -26.2% | -1,0 k € | +28.9% | -1,4 k € | -862.8% | 187,7 € | -98.8% | 15,9 k € | +280.1% | -8,8 k € | -15.5% | -7,6 k € | -650.2% | 1,4 k € | -84.8% | 9,1 k € | +162.8% | 3,5 k € | +16.8% | 3,0 k € | +2267.7% | -137,1 € | -102.7% | 5,0 k € | +146.5% | -10,7 k € | -162.1% | -4,1 k € | |
| Operating profit | -2,6 k € | -46.2% | -1,8 k € | +38.2% | -2,9 k € | -29.6% | -2,3 k € | -27.4% | -1,8 k € | +1.7% | -1,8 k € | -13.7% | -1,6 k € | +11.6% | -1,8 k € | -6.5% | -1,7 k € | -111.7% | 14,4 k € | +263.6% | -8,8 k € | -15.5% | -7,6 k € | -638.6% | 1,4 k € | -93.1% | 20,6 k € | +489.2% | 3,5 k € | +210.5% | -3,2 k € | -180.6% | 3,9 k € | +4194.3% | -96,1 € | +95.2% | -2,0 k € | -4874.0% | -40,1 € | |
| Profit/loss | -2,9 k € | -61.4% | -1,8 k € | +39.2% | -3,0 k € | -31.7% | -2,3 k € | -25.8% | -1,8 k € | +1.6% | -1,8 k € | -13.8% | -1,6 k € | +11.7% | -1,8 k € | +31.4% | -2,6 k € | -118.7% | 14,2 k € | +256.1% | -9,1 k € | -15.5% | -7,9 k € | -666.4% | 1,4 k € | -93.3% | 20,6 k € | +490.1% | 3,5 k € | +208.2% | -3,2 k € | -182.4% | 3,9 k € | +2663.1% | -152,9 € | +93.1% | -2,2 k € | -274.2% | -588,3 € | |
| Equity | 34,7 k € | -7.8% | 37,6 k € | -4.6% | 39,4 k € | -7.0% | 42,4 k € | -5.1% | 44,7 k € | -3.9% | 46,5 k € | -3.8% | 48,3 k € | -3.2% | 49,9 k € | -3.5% | 51,7 k € | -4.9% | 54,3 k € | +35.2% | 40,2 k € | -18.4% | 49,3 k € | -13.7% | 57,1 k € | +2.5% | 55,7 k € | +58.7% | 35,1 k € | +11.0% | 31,6 k € | -9.3% | 34,8 k € | +12.7% | 30,9 k € | -0.5% | 31,1 k € | -6.6% | 33,3 k € | |
| Total assets | 38,7 k € | +0.5% | 38,5 k € | -3.2% | 39,8 k € | -6.1% | 42,4 k € | -5.8% | 45,0 k € | -3.1% | 46,5 k € | -3.8% | 48,3 k € | -3.2% | 49,9 k € | -3.5% | 51,7 k € | -15.4% | 61,1 k € | -22.2% | 78,6 k € | -9.2% | 86,5 k € | +3.1% | 84,0 k € | -25.9% | 113,4 k € | +21.4% | 93,3 k € | +4.7% | 89,1 k € | -4.7% | 93,5 k € | -1.1% | 94,6 k € | -10.6% | 105,8 k € | +85.6% | 57,0 k € | |
| Cash | 103,3 € | +33.9% | 77,2 € | +10.2% | 70,0 € | -3.4% | 72,5 € | -83.8% | 446,4 € | +454.1% | 80,6 € | -58.9% | 196,2 € | +117.2% | 90,3 € | -95.7% | 2,1 k € | +1008.4% | 187,9 € | -84.8% | 1,2 k € | +100.1% | 617,6 € | -36.9% | 978,0 € | -44.4% | 1,8 k € | +77.3% | 991,1 € | -53.3% | 2,1 k € | +20.6% | 1,8 k € | +80.8% | 972,3 € | -78.9% | 4,6 k € | +182.3% | 1,6 k € | |
| Debts | 4,0 k € | +347.2% | 899,7 € | +145.1% | 367,1 € | — | 347,5 € | — | — | — | — | 6,8 k € | -82.3% | 38,4 k € | +3.0% | 37,3 k € | +38.9% | 26,8 k € | -53.4% | 57,6 k € | -1.0% | 58,2 k € | +1.3% | 57,5 k € | -2.0% | 58,7 k € | -7.8% | 63,7 k € | -14.8% | 74,7 k € | +215.1% | 23,7 k € | ||||||||
| Staff | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 0,3 | 0,6 | ||||||||||||||||||||
Private limited company · Bruxelles · incorporated on 05/01/2001
Private limited company loss-making in the latest fiscal year. Cash position rising (+33.9%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DISTRIDENTA is a Private limited company incorporated in 2001. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Bruxelles.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette